Adjuvant zoledronic acid and letrozole plus ovarian function suppression in premenopausal breast cancer: HOBOE phase 3 randomised trial.
Eur J Cancer
; 118: 178-186, 2019 09.
Article
in En
| MEDLINE
| ID: mdl-31164265
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Ovary
/
Tamoxifen
/
Breast Neoplasms
/
Antineoplastic Combined Chemotherapy Protocols
/
Triptorelin Pamoate
/
Premenopause
/
Aromatase Inhibitors
/
Estrogen Antagonists
/
Bone Density Conservation Agents
/
Zoledronic Acid
Type of study:
Clinical_trials
Limits:
Adult
/
Female
/
Humans
/
Middle aged
Country/Region as subject:
Europa
Language:
En
Journal:
Eur J Cancer
Year:
2019
Type:
Article